Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

21.33
Delayed Data
As of Jul 31
 +0.28 / +1.33%
Today’s Change
11.87
Today|||52-Week Range
23.67
+33.40%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close21.05
Today’s open21.15
Day’s range21.05 - 21.69
Volume120,571
Average volume (3 months)169,776
Market cap$723.9M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+910.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio421.6
Price/Sales9.15
Price/Book8.61

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.48+1.81%
AGENAgenus Inc+0.15+1.79%
FMIFoundation Medicine ...-2.00-8.99%
OVASOvaScience Inc+0.35+1.24%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lode Debrabandere
Chief Financial Officer, Secretary &
Treasurer
Philip R. Jacoby
Corporate headquarters
Columbia, Maryland

Forecasts